Literature DB >> 2785507

The prevalence of hepatitis A and B in Norwegian merchant seamen--a serological study.

J C Siebke1, N Wessel, P Kvandal, T Lie.   

Abstract

The prevalence of viral hepatitis in Norwegian merchant seamen in overseas trade was studied in 523 volunteers during compulsory health control before embarkation from the port of Oslo. The prevalence of hepatitis B markers was 9.4%, which is significantly higher than in the general Norwegian population. The prevalence increased with the number of years of occupation. It was associated with frequent casual sexual contacts in foreign countries, but not significantly increased in participants who had been exposed to tattooing or different types of medical treatment under poor hygienic conditions in foreign areas. The prevalence of antibodies against hepatitis A (HAV) was 36% in seamen born in 1945 or earlier and 5% in younger individuals, an age-dependent pattern which is essentially similar in the general Norwegian population. However, the prevalence of hepatitis A antibodies seemed to increase with years in foreign trade. The incidence of viral hepatitis infections in the occupation was noticeably high, suggesting that vaccination of seamen in certain areas of trade should be considered.

Entities:  

Mesh:

Year:  1989        PMID: 2785507     DOI: 10.1007/bf01646880

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  10 in total

1.  Staphylococcal radioimmunoassay for hepatitis B antigen and antibody.

Authors:  K J Figenschau; J C Ulstrup
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1974-06

2.  Prevalence and clinical effects of delta agent. Infections in Norwegian population subgroups.

Authors:  J C Siebke; B von der Lippe; B G Hansson; E Nordenfelt; M Degré
Journal:  Scand J Infect Dis       Date:  1986

3.  Enzyme-immunoassay in diagnosis of hepatitis with emphasis on the detection of "e" antigen (HBeAg).

Authors:  M von der Waart; A Snelting; J Cichy; G Wolters; A Schuurs
Journal:  J Med Virol       Date:  1978       Impact factor: 2.327

4.  Antibody to hepatitis B surface antigen among employees in the National Hospital, Oslo, Norway: a prevalence study.

Authors:  B Hovig; H Rollag; O Dahl
Journal:  Am J Epidemiol       Date:  1985-07       Impact factor: 4.897

5.  Frequency of hepatitis in dental health personnel in Norway.

Authors:  B Hurlen; S B Iversen; J Jonsen
Journal:  Acta Odontol Scand       Date:  1979       Impact factor: 2.331

Review 6.  Advances in viral hepatitis. Report of the WHO Expert Committee on Viral Hepatitis.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  1977

7.  Occupational exposure to hepatitis B virus in hospital personnel: infection or immunization?

Authors:  J L Dienstag; D M Ryan
Journal:  Am J Epidemiol       Date:  1982-01       Impact factor: 4.897

8.  Prevalence of hepatitis A antibodies in a normal population and some selected groups of patients in Norway.

Authors:  J C Siebke; M Degré; S Ritland; S C Enger
Journal:  Am J Epidemiol       Date:  1982-02       Impact factor: 4.897

9.  Hepatitis B virus transmission between heterosexuals.

Authors:  M J Alter; J Ahtone; I Weisfuse; K Starko; T D Vacalis; J E Maynard
Journal:  JAMA       Date:  1986-09-12       Impact factor: 56.272

10.  Prevalence of viral hepatitis in the staff in Norwegian anaesthesiology units.

Authors:  J C Siebke; M Degré
Journal:  Acta Anaesthesiol Scand       Date:  1984-10       Impact factor: 2.105

  10 in total
  3 in total

1.  Hepatitis B markers in heterosexual patients attending two genitourinary medicine clinics in the West Midlands.

Authors:  A A el-Dalil; D T Jayaweera; M Walzman; K W Radcliffe; R Richmond; A A Wade; M Shahmanesh
Journal:  Genitourin Med       Date:  1997-04

2.  A survey on hepatitis B vaccination policies in genitourinary medicine in UK and Ireland.

Authors:  A el-Dalil; K W Radcliffe; J Bailey; R A Richmond; A A Wade
Journal:  Genitourin Med       Date:  1995-08

3.  Tattooing and transfusion-transmitted diseases in Brazil: a hospital-based cross-sectional matched study.

Authors:  Sérgio A de Nishioka; T W Gyorkos; L Joseph; J P Collet; J D MacLean
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.